19.5 million Vaccinated with MenAfriVac
By the end of 2010, 19.5 million people had received MenAfriVac.
MenAfriCar Meeting, London
The London School of Hygiene and Tropical Medicine hosted a MenAfriCar meeting in central London from the 1st to the 3rd of December 2010.
New Meningitis Vaccine Launched
6 December 2010 marks the introduction of a revolutionary new meningitis vaccine, MenAfriVac, in Burkina Faso.
Cross-sectional Studies Underway
MenAfriCar consortium members are currently conducting cross-sectional surveys of meningococcal carriage in Chad, Ethiopia, Ghana, Mali, Niger, Nigeria, and Senegal.
MenAfriCar Capacity Development in Nigeria
MenAfriCar provides funding for candidate to undertake Masters degree in Infectious Diseases.
New Meningitis Vaccine a "Revolution"
The recent launch of a new meningococcal A conjugate vaccine marks a “revolution” in preventing the highly contagious and fatal disease.
Pilot Study Completed
In late 2009, pilot studies of meningococcal carriage amongst children were carried out in Chad, Ethiopia, Ghana, Mali, Niger, Nigeria, and Senegal.
Teleform Training Workshop for Data Managers
The Centre pour les Vaccins en Développement hosted a data management Teleform training workshop at the Nord-Sud Azalai Hotel in Bamako, Mali on April 14th and 15th.
PCR Training Workshop
In March 2010, MenAfriCar consortium members from seven African research centres attended a four day PCR training workshop at CERMES in Niamey, Niger.
MenAfriCar Holds Second Annual Consortium Meeting
The Armauer Hansen Research Institute hosted the successful meeting of 50 delegates from all partnering institutes in Addis Ababa, 20 to 22 January 2010.